157 related articles for article (PubMed ID: 27800629)
1. The combination of pharmacogenetic and pharmacokinetic analyses to optimize clomipramine dosing in major depression: a case report.
Antoniazzi S; Tatulli A; Falvella FS; Cigliobianco M; Paoli RA; Cattaneo D; Cheli S; Bernardi FF; Clementi E; Altamura CA
J Clin Pharm Ther; 2017 Feb; 42(1):119-121. PubMed ID: 27800629
[TBL] [Abstract][Full Text] [Related]
2. [Therapeutic drug monitoring: A pharmacotherapeutic tool in psychiatry].
Stephan PL; Etzensberger M; Jaquenoud Sirot E
Praxis (Bern 1994); 2006 Apr; 95(17):671-8. PubMed ID: 16686323
[TBL] [Abstract][Full Text] [Related]
3. Age-related adverse drug reactions to clomipramine.
Stage KB; Kragh-Sørensen PB;
Acta Psychiatr Scand; 2002 Jan; 105(1):55-9. PubMed ID: 12086226
[TBL] [Abstract][Full Text] [Related]
4. Clomipramine and glucocorticoid receptor function.
Carroll BJ
Neuropsychopharmacology; 2009 Aug; 34(9):2192-3; author reply 2194-5. PubMed ID: 19404244
[No Abstract] [Full Text] [Related]
5. Clomipramine dose-effect study in patients with depression: clinical end points and pharmacokinetics. Danish University Antidepressant Group (DUAG).
Clin Pharmacol Ther; 1999 Aug; 66(2):152-65. PubMed ID: 10460069
[TBL] [Abstract][Full Text] [Related]
6. Multicenter study on the clinical effectiveness, pharmacokinetics, and pharmacogenetics of mirtazapine in depression.
Jaquenoud Sirot E; Harenberg S; Vandel P; Lima CA; Perrenoud P; Kemmerling K; Zullino DF; Hilleret H; Crettol S; Jonzier-Perey M; Golay KP; Brocard M; Eap CB; Baumann P
J Clin Psychopharmacol; 2012 Oct; 32(5):622-9. PubMed ID: 22926595
[TBL] [Abstract][Full Text] [Related]
7. Clinical efficacy of tandospirone augmentation in patients with major depressive disorder: a randomized controlled trial.
Yamada K; Yagi G; Kanba S
Psychiatry Clin Neurosci; 2003 Apr; 57(2):183-7. PubMed ID: 12667165
[TBL] [Abstract][Full Text] [Related]
8. [Therapeutic drug monitoring in depression--new perspectives].
Radziwoń-Zaleska M; Matsumoto H; Skalski M; Dziklińska A; Androsiuk W; Wakarow A; Wilkowska J; Matoszko D; Kuczyńska J; Goluch J
Psychiatr Pol; 2002; 36(6 Suppl):71-80. PubMed ID: 12647424
[TBL] [Abstract][Full Text] [Related]
9. Metabolic interaction between fluoxetine and clomipramine: a case report.
Balant-Gorgia AE; Ries C; Balant LP
Pharmacopsychiatry; 1996 Jan; 29(1):38-41. PubMed ID: 8852534
[TBL] [Abstract][Full Text] [Related]
10. [Fluoxetine and tricyclic antidepressants: clinical tolerance in short-term combined administration].
Bonin B; Bertschy G; Baumann P; Francois T; Vandel P; Vandel S; Sechter D; Bizouard P
Encephale; 1996; 22(3):221-7. PubMed ID: 8767051
[TBL] [Abstract][Full Text] [Related]
11. Effects of physiological covariables on pharmacokinetic parameters of clomipramine in a large population of cats after a single oral administration.
Lainesse C; Frank D; Beaudry F; Doucet M
J Vet Pharmacol Ther; 2007 Apr; 30(2):116-26. PubMed ID: 17348896
[TBL] [Abstract][Full Text] [Related]
12. Therapeutic drug monitoring of clomipramine and amitriptyline in a depressed patient with upper digestive tract resection.
Couturier PL; Zahr N; Goldwirt L; Warot D; Allilaire JF; Lambrey S
Ther Drug Monit; 2011 Aug; 33(4):467-8. PubMed ID: 21743378
[TBL] [Abstract][Full Text] [Related]
13. Adverse drug reactions following nonresponse in a depressed patient with CYP2D6 deficiency and low CYP 3A4/5 activity.
Stephan PL; Jaquenoud Sirot E; Mueller B; Eap CB; Baumann P
Pharmacopsychiatry; 2006 Jul; 39(4):150-2. PubMed ID: 16871470
[TBL] [Abstract][Full Text] [Related]
14. Molecular network-selected pharmacogenomics in a case of bipolar spectrum disorder.
Fortinguerra S; Buriani A; Sorrenti V; Lenzi M; Giusti P
Pharmacogenomics; 2017 Dec; 18(18):1631-1642. PubMed ID: 29173093
[TBL] [Abstract][Full Text] [Related]
15. [Tricyclic antidepressants dosage and depressed elderly inpatients: a retrospective pharmaco-epidemiologic study].
Ballon N; Siobud-Dorocant E; Even C; Slama F; Dardennes R
Encephale; 2001; 27(4):373-6. PubMed ID: 11686060
[TBL] [Abstract][Full Text] [Related]
16. [Tricyclic antidepressive agents in refractory depressions].
Plantey F
Nouv Presse Med; 1977 Sep; 6(29):2608-9. PubMed ID: 909749
[No Abstract] [Full Text] [Related]
17. [Intravenous clomipramine for depressive disorders].
Landowski J; Lamparska E; Wichowicz H; Gizińska D; Godlewska B; Wiglusz M
Psychiatr Pol; 2002; 36(6 Suppl):85-91. PubMed ID: 12647426
[TBL] [Abstract][Full Text] [Related]
18. Interaction of modafinil and clomipramine as comedication in a narcoleptic patient.
Grözinger M; Härtter S; Hiemke C; Griese EU; Röschke J
Clin Neuropharmacol; 1998; 21(2):127-9. PubMed ID: 9579300
[TBL] [Abstract][Full Text] [Related]
19. Is there a place for tricyclic antidepressants and subsequent augmentation strategies in obtaining remission for patients with treatment resistant depression?
Gervasoni N; Aubry JM; Gex-Fabry M; Bertschy G; Bondolfi G
Pharmacol Res; 2009 Mar; 59(3):202-6. PubMed ID: 19073260
[TBL] [Abstract][Full Text] [Related]
20. Chronic antidepressant treatment exerts sexually dimorphic immunomodulatory effects in an experimental model of major depression: do females lack an advantage?
Pitychoutis PM; Griva E; Ioannou K; Tsitsilonis OE; Papadopoulou-Daifoti Z
Int J Neuropsychopharmacol; 2009 Oct; 12(9):1157-63. PubMed ID: 19698192
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
